The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial (Q36058200)

11 August 2017

The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial (English)

1 reference

11 August 2017

0 references

6

John R Perfect

1 reference

11 August 2017

Dimitrios P Kontoyiannis

4

object named as

Dimitrios P Kontoyiannis

1 reference

11 August 2017

Brad Spellberg

1

1 reference

11 August 2017

Ashraf S Ibrahim

2

1 reference

11 August 2017

Peter V Chin-Hong

3

1 reference

11 August 2017

Michele I Morris

5

1 reference

11 August 2017

David Fredricks

7

1 reference

11 August 2017

Eric P Brass

8

1 reference

11 August 2017

language of work or name

English

0 references

publication date

20 September 2011

1 reference

11 August 2017

8

1 reference

Journal of Antimicrobial Chemotherapy

inferred from page(s)

published in

1 reference

11 August 2017

67

1 reference

11 August 2017

3

1 reference

11 August 2017

715-722

1 reference

Mortality risk factors in patients with zygomycosis: a retrospective and multicentre study of 25 cases.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Recent advances in the management of mucormycosis: from bench to bedside

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

The iron chelator deferasirox protects mice from mucormycosis through iron starvation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Iron-chelating therapy with the new oral agent ICL670 (Exjade).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Improved outcome of zygomycosis in patients with hematological diseases?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Liposomal Amphotericin B, and Not Amphotericin B Deoxycholate, Improves Survival of Diabetic Mice Infected with Rhizopus oryzae

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Mucormycosis: association with deferoxamine therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Effects of iron and desferrioxamine on Rhizopus infection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Invasive zygomycosis in India: experience in a tertiary care hospital

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Deferiprone iron chelation as a novel therapy for experimental mucormycosis

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Ten years' experience in zygomycosis at a tertiary care centre in India

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383100

The effect of deferoxamine on different zygomycetes

23 September 2018

1 reference

12 December 2020

A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability

1 reference

12 December 2020

Mucormycosis in diabetic ketoacidosis. Role of unbound iron binding capacity of transferrin

1 reference

12 December 2020

Intestinal mucormycosis in hemodialysis patients following deferoxamine

1 reference

12 December 2020

Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine

1 reference

12 December 2020

Identifiers

DOI

10.1093/JAC/DKR375

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

21937481

1 reference